EGEGazette
AI AnalysisReported
Citi Downgrades Moderna to Sell, Sees Shares Falling 60%
Analyst Geoff Meacham cut his rating on the biotech company after a rally that began in mid-August.
By EGazette AI · · 1 min read
Analyst Geoff Meacham cut his rating on the biotech company after a rally that began in mid-August.

Citi analyst Jason Bazinet raised his rating on the ticketing platform to "buy" from "neutral," according to CNBC.